Steve brings over 25 years of senior executive level operating and transaction experience in the biopharmaceutical industry, with expertise in Japanese/Asian markets.  In 2014, he established his own biopharma consultancy, and continues to support western biopharma clients seeking to execute transactions and other strategic initiatives in Japan. Since establishing his firm, Steve has overseen more than twenty transactions (including buy-side and sell-side transactions) between western and Japanese/Chinese biopharma companies.

 

Steve previously headed the Japanese operations of Shire Pharmaceuticals. Before Shire, Steve served as CEO of Solasia Pharma, a cancer-focused development stage company with operations in Japan and China. Steve launched his biopharma career at Purdue Pharma in business development, and then held the position of President of Mundipharma Japan for nine years. In this role, he oversaw the development and commercialization of the company’s leading pain management franchise.

 

Steve and his wife have two daughters, and currently share time between their homes in Bellevue Washington and Tokyo Japan.  Steve is fluent in written and spoken Japanese.

Jennifer Sherr is a pediatric endocrinologist and an Associate Professor of Pediatrics at Yale University School of Medicine. Jennifer was diagnosed with T1D in 1987 and has been devoted to clinical research over the past 11 years. She is an active and integral member of the artificial pancreas team at Yale and focuses her career on clinical strategies to improve closed-loop insulin delivery, for which she received a JDRF Early Career Patient Oriented Diabetes Research Award.

Jennifer has also been involved with studies investigating new glucagon formulations for the treatment of severe hypoglycemia. Jennifer has worked on projects with the T1D Exchange and served as the first Junior Pediatric Faculty Member to its steering committee.

Jennifer holds a B.A. in Biology from Rutgers University and a M.D. from UMDNJ- Robert Wood Johnson Medical School. She completed her fellowship at Yale University School of Medicine and received her Ph.D. in Investigative Medicine from the Yale Graduate School of Arts & Sciences.